Germline BRCA1/2 Mutations and
1 clinical trials · Condition
◉ Watch Germline BRCA1/2 Mutations and
| Record | Firm | Date |
|---|---|---|
| Olaparib in gBRCA Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy (NCT02184195) | AstraZeneca | 2014-12-16 |
Track Germline BRCA1/2 Mutations and automatically
Every clearance here is in the API, with alerts when new ones post.